Arcus Biosciences Inc
RCUS
Market Cap$841.79M
Close$
$20.04
133.3% upside
Current Fair Value
133.3% upsideUndervalued by 133.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $841.79 Million |
|---|---|
| Enterprise Value | $781.79 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-3.14 |
| Beta | 0.83 |
| Outstanding Shares | 98,400,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -2 |
|---|---|
| PEG | -0.07 |
| Price to Sales | 8.59 |
| Price to Book Ratio | 1.72 |
| Enterprise Value to Revenue | 5.54 |
| Enterprise Value to EBIT | -1.83 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.17 |
| Debt to Equity | 0.25 |
Revenue Sources
No data
Insider Trades
ESG Score
No data